| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028622823 |
| P356 | DOI | 10.1245/S10434-015-4402-X |
| P698 | PubMed publication ID | 25727554 |
| P2093 | author name string | Thomas A Buchholz | |
| Amit K Garg | |||
| P2860 | cites work | Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized | Q31089499 |
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials | Q34054354 | ||
| Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy | Q34153737 | ||
| Neoadjuvant chemotherapy for operable breast cancer | Q34663809 | ||
| Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy | Q35087084 | ||
| Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy | Q35087264 | ||
| 12. Cancers in 2010 attributable to ionising radiation exposure in the UK. | Q35654781 | ||
| Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. | Q36368893 | ||
| Physical models and simpler dosimetric descriptors of radiation late toxicity | Q36774560 | ||
| Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference | Q37079615 | ||
| Radiation therapy and breast reconstruction: a critical review of the literature | Q37567226 | ||
| Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. | Q38474424 | ||
| Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall | Q43180234 | ||
| Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation | Q43843446 | ||
| T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy | Q44849167 | ||
| Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy | Q44969838 | ||
| Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy | Q45149799 | ||
| Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study | Q45330030 | ||
| The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05). | Q46011284 | ||
| Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. | Q46765380 | ||
| Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy | Q47182699 | ||
| Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. | Q50554120 | ||
| Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. | Q50561182 | ||
| Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. | Q50563448 | ||
| Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer | Q57617595 | ||
| P433 | issue | 5 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 1434-1440 | |
| P577 | publication date | 2015-03-02 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer | |
| P478 | volume | 22 |
| Q90127228 | Albumin-bioinspired iridium oxide nanoplatform with high photothermal conversion efficiency for synergistic chemo-photothermal of osteosarcoma |
| Q88300432 | Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer |
| Q52967695 | Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. |
| Q90376518 | Patterns of post-operative irradiation in breast cancer patients submitted to neoadjuvant chemotherapy |
| Q38557220 | Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer |
| Q90292135 | Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters |
| Q92483044 | The Adventure of Axillary Treatment in Early Stage Breast Cancer |
Search more.